VTRSViatris Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 23510
Ticker: VTRS
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1973-02-23
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: VTRS

Detail

Enriched 2026-08-14 20:47

Market cap: $18,492,312,910.4
Shares outstanding (class): 1,148,590,864
Shares outstanding (weighted): 1,148,590,864
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 30,000
Location: CANONSBURG, PA
Homepage: https://www.viatris.com
Description: Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Market cap and share counts drift.

Funds holding this security

324 funds · 330 positions · $3.76B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$492.62M	0.02%	36,463,346 NS	FIGI
VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS	VOO	$395.42M	0.03%	29,268,757 NS	FIGI
VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS	VB	$358.67M	0.22%	26,548,768 NS	FIGI
VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS	VBR	$228.40M	0.38%	16,905,994 NS	FIGI
iShares Core S&P 500 ETF iShares Trust	IVV	$200.13M	0.03%	14,813,651 NS	FIGI
N/A —	—	$182.50M	0.03%	13,508,560 NS	FIGI
T. Rowe Price Equity Income Fund T. ROWE PRICE EQUITY INCOME FUND, INC.	—	$152.99M	0.95%	11,324,000 NS	FIGI
State Street(R) Health Care Select Sector SPDR(… SELECT SECTOR SPDR TRUST	XLV	$113.24M	0.29%	8,381,597 NS	FIGI
T. Rowe Price Mid-Cap Value Fund, Inc. T. ROWE PRICE MID-CAP VALUE FUND, INC.	—	$109.48M	0.74%	8,103,484 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 500(R) Hi… SPDR SERIES TRUST	SPYD	$89.58M	1.27%	6,630,860 NS	FIGI
VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS	—	$87.74M	0.03%	6,494,091 NS	FIGI
Selected American Shares SELECTED AMERICAN SHARES INC	—	$87.01M	4.46%	6,440,150 NS	FIGI
iShares Russell Mid-Cap ETF iShares Trust	IWR	$59.53M	0.12%	4,406,238 NS	FIGI
Bridge Builder Large Cap Value Fund Bridge Builder Trust	—	$55.14M	0.21%	4,081,061 NS	FIGI
Columbia Variable Portfolio - Disciplined Core … Columbia Funds Variable Series Trust II	—	$46.52M	1.32%	3,443,446 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERVTRS
FIGI_COMPOSITEBBG00Y4RQNH4
FIGI_SHARE_CLASSBBG00Y52JV51
CIK0001792044
ISINUS92556V1061
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Viatris is a pharmaceutical company, as indicated by its SIC code 2834 for pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.